Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer
2 other identifiers
interventional
40
1 country
1
Brief Summary
This trial studies how well yoga therapy works during chemotherapy and radiation treatment in improving physical and emotional well-being in patients with stage IB2-IIIB cervical cancer. Yoga therapy may help to balance the mind and body through exercise, meditation (focusing thoughts), and control of breathing and emotions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2020
CompletedFirst Submitted
Initial submission to the registry
April 30, 2020
CompletedFirst Posted
Study publicly available on registry
November 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
January 20, 2026
January 1, 2026
6.9 years
April 30, 2020
January 15, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Enrollment to the yoga therapy protocol
90 patients will be screen to obtain at least 40 who are eligible and consent
Baseline up to 3 months post CRT
Adherence to the yoga therapy protocol
At least 10 patients in the YG group must complete at least 50% of the required yoga sessions
Baseline up to 3 months post CRT
Completion in the yoga therapy protocol
At least 25 of the 40 patients must complete any of the follow up measure between T3 and T5 in order to declare this study feasible
Baseline up to 3 months post CRT
Study Arms (2)
Group I (yoga group)
EXPERIMENTALPatients attend at least 2 yoga classes per week over 5-6 weeks lasting approximately 60 minutes each for up to 15 classes during the CRT. Patients also complete surveys pre-treatment, once a week, and post-treatment over and receive a yoga manual and DVD during and after CRT.
Group II (wait list control)
ACTIVE COMPARATORPatients refrain from participating in any new stress management activities and receive a DVD. Patients are also offered 4 group yoga classes after 3 months of CRT. Patients also complete surveys as in Group I.
Interventions
Ancillary studies
Eligibility Criteria
You may qualify if:
- Score of =\< 2 on Eastern Cooperative Oncology Group (ECOG) performance scale
- Able to speak English
- Federation of Gynecology and Obstetrics (FIGO) stage IB2 through IIIB biopsy-proven CxCa (adenocarcinoma, squamous cell carcinoma, and adenosquamous) with plan to undergo curative outpatient CRT at main campus MD Anderson Cancer Center
You may not qualify if:
- Medically documented restrictions at enrollment that could interfere with participation in the yoga interventions (i.e. uncontrolled vaginal bleeding)
- Medical illness that would prevent administration of full-dose chemotherapy
- Concurrent diagnosis of a second cancer
- Prior hysterectomy
- Neuroendocrine histology
- Patients who are pregnant
- It is standard procedure to administer a pregnancy test before the start of CRT. Patients are deemed not pregnant by virtue of urine pregnancy test (UPT) or testing of the blood. Due to radiation and the nature of the disease, a patient becoming pregnant while on study is highly unlikely. In the event a patient were to get pregnant, they would be removed from study because their radiation therapy (RT) might be stopped or fetus would be terminated, which might influence other parameters that are being measured
- Patients with major psychiatric diagnoses (e.g., schizophrenia, bipolar disorder)
- Patients with extreme mobility issues, and
- Patients who have had a regular yoga practice (at least one time a month) in past 6 months prior to study enrollment or who are currently engaged in a regular mind-body practice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lois M Ramondetta, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 30, 2020
First Posted
November 10, 2020
Study Start
March 10, 2020
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
January 31, 2027
Last Updated
January 20, 2026
Record last verified: 2026-01